265 related articles for article (PubMed ID: 30513231)
21. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
23. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
Riggs PD; Leon SL; Mikulich SK; Pottle LC
J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1271-8. PubMed ID: 9847499
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
25. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
Steinhausen HC; Bisgaard C
Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
[TBL] [Abstract][Full Text] [Related]
26. Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.
Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
BMC Psychiatry; 2013 Dec; 13():336. PubMed ID: 24330331
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.
Biederman J; Wilens T; Mick E; Spencer T; Faraone SV
Pediatrics; 1999 Aug; 104(2):e20. PubMed ID: 10429138
[TBL] [Abstract][Full Text] [Related]
28. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.
van Emmerik-van Oortmerssen K; Vedel E; Koeter MW; de Bruijn K; Dekker JJ; van den Brink W; Schoevers RA
BMC Psychiatry; 2013 May; 13():132. PubMed ID: 23663651
[TBL] [Abstract][Full Text] [Related]
29. The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorder.
Donovan SJ; Levin FR
Am J Drug Alcohol Abuse; 2011 Jul; 37(4):235-9. PubMed ID: 21517711
[TBL] [Abstract][Full Text] [Related]
30. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
[TBL] [Abstract][Full Text] [Related]
31. Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.
Zaso MJ; Park A; Antshel KM
J Atten Disord; 2020 Jul; 24(9):1215-1226. PubMed ID: 25655767
[No Abstract] [Full Text] [Related]
32. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
Tamm L; Adinoff B; Nakonezny PA; Winhusen T; Riggs P
Am J Drug Alcohol Abuse; 2012 Jan; 38(1):93-100. PubMed ID: 21834613
[TBL] [Abstract][Full Text] [Related]
33. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
[TBL] [Abstract][Full Text] [Related]
34. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.
Young JT; Carruthers S; Kaye S; Allsop S; Gilsenan J; Degenhardt L; van de Glind G; van den Brink W; Preen D
Drug Alcohol Rev; 2015 Nov; 34(6):683-93. PubMed ID: 25790353
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study.
Kast KA; Rao V; Wilens TE
J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988929
[TBL] [Abstract][Full Text] [Related]
36. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
[TBL] [Abstract][Full Text] [Related]
37. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
[TBL] [Abstract][Full Text] [Related]
38. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Ottosen C; Petersen L; Larsen JT; Dalsgaard S
J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
[TBL] [Abstract][Full Text] [Related]
39. Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
Coetzee C; Schellekens AFA; Truter I; Meyer A
Eur Addict Res; 2023; 29(1):9-18. PubMed ID: 36349763
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: a naturalistic study.
Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
J Subst Abuse Treat; 2015 Apr; 51():82-90. PubMed ID: 25491733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
